Pharmacologic Management of COPD: An Official ATS Clinical Practice Guideline
- Nici L, Mammen MJ, Charbek E, Alexander PE, Au DH, Boyd CM et al. Pharmacologic management of COPD: an official ATS clinical practice guideline. Am J Respir Crit Care Med 2020; 201(9):e56-369.
- Gartman EJ, Mulpuru SS, Mammen MJ, Alexander PE, Nici L, Aaron SD, et al. Summary for clinicians: clinical practice guideline on pharmacologic management of chronic obstructive pulmonary disease. Ann Am Thorac Soc 2020; 18(1):11-16.
- Systematic Reviews
- Mammen MJ, Pai V, Aaron SD, Nici L, Alhazzani W and Alexander PE. Dual LABA/LAMA therapy versus LABA or LAMA monotherapy for chronic obstructive pulmonary disease. A systematic review and meta-analysis in support of the ATS clinical practice guideline. Ann Am Thorac Soc 2020; 17(9):1133-1143.
- Mammen MJ, Lloyd DR, Kumar S, Ahmed AS, Pai V, Kunadharaju R, et al. Triple therapy versus dual or monotherapy with long-acting bronchodilators for chronic obstructive pulmonary disease. A systematic review and meta-analysis. Ann Am Thorac Soc 2020; 17(10):1308-1318.
- Halpin DMG, Criner GJ, Papi A, Singh D, Anzueto A, Martinez Fj, et al. Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2021; 203(1):24-36.
- ECRI Institute Guideline Summary and Scorecard
- Pre-registration required for free access.
- Editorials and Letters to the Editor
- Calverley, PMA. Guidance for the better care of COPD patients. Am J Respir Crit Care Med 2020; 201(9):1022-1023.
- Press Release
- Related Public Health Interest Materials
- Medicines for COPD (2021)
- Chronic Obstructive Pulmonary Disease (COPD) (2021)
- Signs and Symptoms of COPD (2019)
- Guideline Central Pocket Guide
Complementary Materials
- Related Systematic Review
- Cellie BR, Anderson JA, Cowans NJ, Crim C, Hartley BF, Martinez FJ, et al. Pharmacotherapy and lung function decline in patients with chronic obstructive pulmonary disease. A systematic review. Am J Respir Crit Care Med 2021; 203(6):689–698.
- Related Statements and Workshop Reports
- Press VG, Au DH, Bourbeau J, Dransfield MT, Gershon AS, Krishnan JA. Reducing chronic obstructive pulmonary disease hospital readmissions. an official ATS workshop report. Ann Am Thorac Soc 2019; 16(2):161-170.
- Related Editorials and Letters to the Editor
- Cozier YC and Govender P. Sarcoidosis: An ill-afforded disease. Am J Respir Crit Care Med 2020; 201(8):890-891.
- General Reviews and Updates
- Sethi S and Aaron SD. Antibiotic re-treatment for acute exacerbations of COPD. Am J Respir Crit Care Med 2020; 202(4):481-482.
- Labaki WW, Kimmig LM, Mutlu GM et al. Update in chronic obstructive pulmonary disease 2018. Am J Respir Crit Care Med 2019; 199(12), pp. 1462–1470
- Related CME
- Related Scientific Symposia
- Related Public Health Interest Materials
- Surgery for COPD (2019)
- Exacerbation of COPD (2018)
- Related Pocket Guides
- Related Podcasts
- Clinician to Clinician: Gaps in the Diagnosis, Assessment, and Treatment of COPD, January 2019 (Dr. Gerard Criner joins Dr. Gregory Tino)
- Understanding Early Chronic Obstructive Pulmonary Disease (COPD), January 2019 (Dr. Francesca Polverino with Dr. Enid Neptune)
- Out of the Blue: An AJRCCM Podcast - GOLD 2017 Report: What You Need to Know, Mar. 1, 2017 (Dr. Jadwiga Wedzicha joins Dr. Nitin Seam)
- SUNSET Trial: De-escalating ICS Therapy in COPD, September 2018 (Dr. Lucian Marts)
- Related Webinars
- Alpha-1/COPD Lunge Disease Week Presentations (Dec. 8, 2018)
- The Future of COPD Treatment (Nov. 11, 2015) - Presenter: Robert Sandhaus, MD, PhD, FCCP
- Alpha-1/COPD Lunge Disease Week Presentations (Dec. 8, 2018)
